Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by canadapieton Jan 11, 2019 3:34pm
176 Views
Post# 29220615

RE:RE:RE:Share price

RE:RE:RE:Share pricedubble..,dubble , sorry , from Belgium but i do my best ! But hey, no problemo! 

And we have with GLPG(biotech, of course) here a CEO who cares for his shareholders, even the little ones like many of us. 
I told all here that i sold most of my shares, because sales lagged, so i think that was just lucky me. I am allready very long in this share and know that with biotech you need to have patience! But if things turn out not the way it was promised, selling is not to be ashamed of. And if you look at the chart, the bottom could be in like i said. And if you listen to competent guys like you an "palinc" and "Spceo" and others, i thought it could be a good time to buy again. Do not forget that 3 days ago we were nearly at 10, so still 25% to go ! 

I am following 30 years the biotech market  and did very well. I know that a MB can be a wonderful place to gain information, and this MB (our MB) is one of the best! It is hard to follow the Canadian market from here , so i am very thankfull!!! 

Really the best for all the people with good intentions !
And thx again! 

Canadapiet


Bullboard Posts